VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TRNS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TRNSTranscat, Inc.
$100.12$937M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTRNSFinancials

Transcat, Inc. (TRNS) Income Statement

30Y historyFree accessUpdated daily

Revenue has accelerated to $92.9M in 2027Q1, but this growth is decoupling from profitability as the operating margin has compressed 900 basis points to 4.0% since 2024Q4, while SG&A expenses have nearly doubled to $27.0M.

Income StatementBalance SheetCash FlowRatios

TRNS Income Statement

Annual statement

TRNS Income Statement

Transcat, Inc. (TRNS) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01Mar'00Mar'99Mar'98
Sales/Revenue363.22M331.88M278.42M259.48M230.57M204.96M173.34M173.1M160.9M155.14M143.9M143.9M122.17M123.62M118.51M112.3M110.02M91.19M81.06M75.42M70.45M66.47M60.47M55.31M53.32M57.18M66.78M75.57M79.97M69.7M78.5M
Revenue Growth %19.34%19.2%7.3%12.54%12.5%18.24%0.14%7.58%3.71%7.81%17.79%17.79%-1.18%4.32%5.53%2.07%20.65%12.49%7.48%7.05%5.99%9.93%9.34%3.73%-6.76%-14.38%-11.63%-5.5%14.73%-11.21%65.96%
Cost of Goods Sold244.13M223.57M188.97M175.68M162.21M146.52M127.22M130.62M121.56M117.7M108.93M108.93M93.05M94.54M88.72M84.89M82.9M67.89M61.77M56.67M51.91M49.78M45.37M41.41M39.92M43.9M49.14M47.98M52.98M43.4M50.7M
COGS % of Revenue-67.37%67.87%67.7%70.35%71.49%73.39%75.46%75.55%75.87%75.7%75.7%76.16%76.47%74.86%75.6%75.35%74.45%76.2%75.14%73.68%74.89%75.03%74.88%74.87%76.77%73.58%63.5%66.25%62.27%64.59%
Gross Profit119.08M108.3M89.45M83.81M68.36M58.44M46.12M42.48M39.34M37.44M34.97M34.97M29.12M29.09M29.79M27.4M27.12M23.3M19.29M18.75M18.54M16.69M15.1M13.89M13.4M13.29M17.64M27.58M26.99M26.3M27.8M
Gross Margin %32.79%32.63%32.13%32.3%29.65%28.51%26.61%24.54%24.45%24.13%24.3%24.3%23.84%23.53%25.14%24.4%24.65%25.55%23.8%24.86%26.32%25.11%24.97%25.12%25.13%23.23%26.42%36.5%33.75%37.73%35.41%
Gross Profit Growth %-21.07%6.74%22.6%16.97%26.72%8.57%7.97%5.08%7.07%20.09%20.09%0.11%-2.36%8.71%1.03%16.42%20.75%2.91%1.12%11.09%10.54%8.69%3.69%0.84%-24.7%-36.04%2.21%2.62%-5.4%41.84%
Operating Expenses107.02M95.04M71.58M64.03M52.11M44.3M35.05M31.63M29.11M28.41M27.04M27.04M22.82M22.32M23.09M21.46M21.7M18.71M16.91M16.06M15.26M14.34M13.58M12.99M13.09M12.85M23.65M24.63M26.87M22.5M23.6M
OpEx % of Revenue-28.64%25.71%24.67%22.6%21.61%20.22%18.27%18.09%18.32%18.79%18.79%18.68%18.05%19.48%19.11%19.72%20.52%20.86%21.3%21.66%21.57%22.46%23.49%24.55%22.48%35.41%32.6%33.6%32.28%30.06%
Selling, General & Admin107.42M95.04M71.58M64.03M52.11M44.3M35.05M31.63M29.11M28.41M27.04M27.04M22.82M22.32M23.09M21.46M21.7M18.71M16.91M16.06M15.26M14.34M13.58M12.99M13.09M12.85M18.24M18.92M20.55M17.8M19.2M
SG&A % of Revenue-28.64%25.71%24.67%22.6%21.61%20.22%18.27%18.09%18.32%18.79%18.79%18.68%18.05%19.48%19.11%19.72%20.52%20.86%21.3%21.66%21.57%22.46%23.49%24.55%22.48%27.31%25.04%25.69%25.54%24.46%
Research & Development00000000000000000000000000901K1.17M1.51M1.6M1.7M
R&D % of Revenue--------------------------1.35%1.54%1.89%2.3%2.17%
Other Operating Expenses-400K00000000000000000000000004.51M4.55M4.81M3.1M2.7M
Operating Income12.06M13.26M17.87M19.78M16.25M14.14M11.07M10.85M10.23M9.03M7.93M7.93M6.3M6.77M6.71M5.95M5.43M4.59M2.38M2.69M3.28M3.89M1.52M899K307K434K-6M2.95M121.39K3.8M4.2M
Operating Margin %3.32%4%6.42%7.62%7.05%6.9%6.39%6.27%6.36%5.82%5.51%5.51%5.16%5.47%5.66%5.29%4.93%5.03%2.94%3.56%4.66%5.86%2.51%1.63%0.58%0.76%-8.99%3.91%0.15%5.45%5.35%
Operating Income Growth %--25.8%-9.64%21.74%14.88%27.73%2.06%6.07%13.33%13.76%25.9%25.9%-6.89%0.94%12.76%9.54%18.33%92.65%-11.36%-18.18%-15.67%156.46%68.85%192.83%-29.26%107.23%-303.45%2331.51%-96.81%-9.52%23.53%
EBITDA39.99M39.44M36.44M33.33M27.2M23.71M18.65M17.51M16.59M15.02M14.12M14.12M10.25M9.86M9.65M8.65M8.32M6.88M4.46M4.58M5.04M5.57M2.96M2.52M1.71M2.48M2.59M7.5M4.93M6.9M6.9M
EBITDA Margin %11.01%11.88%13.09%12.84%11.8%11.57%10.76%10.12%10.31%9.68%9.81%9.81%8.39%7.97%8.14%7.7%7.57%7.54%5.5%6.08%7.16%8.37%4.9%4.56%3.2%4.34%3.88%9.92%6.16%9.9%8.79%
EBITDA Growth %-7.57%8.22%9.35%22.5%14.73%27.11%6.53%5.54%10.47%6.37%37.76%37.76%3.96%2.16%11.59%3.89%20.99%54.23%-2.66%-9.14%-9.39%87.76%17.66%47.8%-31.28%-4.17%-65.47%52.12%-28.57%0%56.82%
D&A (Non-Cash Add-back)27.93M26.17M18.57M13.54M10.96M9.57M7.58M6.66M6.36M5.99M6.18M6.18M3.95M3.09M2.94M2.7M2.9M2.29M2.08M1.9M1.76M1.67M1.45M1.62M1.4M2.05M8.59M4.55M4.81M3.1M2.7M
EBIT12.87M12.59M19.12M20.27M15.9M14M11.07M10.85M10.23M9.13M7.93M7.93M6.3M6.77M7M5.95M5.43M4.55M2.35M2.62M3.28M2.35M1.36M606K307K469K-6M2.95M121.39K3.8M4.1M
Net Interest Income-6.1M-5.27M27K-1.03M-2.42M-810K-1.09M-1.12M-994K-1.08M-770K-770K-295K-345K-259K-228K-182K-73K-63K-100K00000000000
Interest Income2K0825K808K000000000000-48K00000000000000
Interest Expense6.11M5.27M798K1.83M2.42M810K1.09M1.12M994K1.08M770K770K295K345K259K228K134K73K63K100K101K334K427K350K434K615K00000
Other Income/Expense-5.3M-5.27M452K-1.34M-2.76M-953K-1.09M-1.12M-994K-1.08M-770K-770K-295K-345K-259K-228K-182K-105K-98K-167K-538K-617K-589K-643K-146K915K-1.23M-2.52M-2.93M-2.1M-2.5M
Pretax Income6.76M7.99M18.33M18.44M13.49M13.19M9.98M9.73M9.23M7.95M7.16M7.16M6.01M6.42M6.45M5.72M5.25M4.48M2.28M2.52M2.75M3.28M929K256K161K1.35M-7.23M428.74K-2.81M1.7M1.6M
Pretax Margin %1.86%2.41%6.58%7.11%5.85%6.44%5.76%5.62%5.74%5.12%4.98%4.98%4.92%5.2%5.44%5.09%4.77%4.92%2.82%3.34%3.9%4.93%1.54%0.46%0.3%2.36%-10.83%0.57%-3.51%2.44%2.04%
Income Tax2.17M2.61M3.81M4.79M2.8M1.81M2.19M1.66M2.09M2.03M2.64M2.64M1.88M2.4M2.46M2.01M1.94M1.69M832K963K382K1.22M-2.65M0-192K-408K-600K-84.4K-319K700K600K
Effective Tax Rate %32.1%32.71%20.8%25.99%20.75%13.72%21.95%17.09%22.63%25.49%36.88%36.88%31.35%37.32%38.19%35.22%37.06%37.8%36.44%38.23%13.92%37.15%-285.04%0%-119.25%-30.24%8.3%-19.69%11.36%41.18%37.5%
Net Income4.59M5.38M14.52M13.65M10.69M11.38M7.79M8.07M7.14M5.92M4.52M4.52M4.12M4.03M3.98M3.7M3.3M2.79M1.45M1.56M2.36M2.06M3.58M256K353K-4.71M-6.63M513.14K-2.49M1M1M
Net Margin %1.26%1.62%5.21%5.26%4.64%5.55%4.49%4.66%4.44%3.82%3.14%3.14%3.38%3.26%3.36%3.3%3%3.06%1.79%2.06%3.35%3.1%5.92%0.46%0.66%-8.25%-9.93%0.68%-3.11%1.43%1.27%
Net Income Growth %-65.96%-62.96%6.36%27.69%-6.08%46.07%-3.42%12.9%20.65%30.96%9.65%9.65%2.43%1.05%7.56%12.17%18.44%92.14%-6.75%-34.15%14.76%-42.44%1297.27%-27.48%107.49%28.89%-1392.23%120.61%-349.01%0%-52.38%
Net Income (Continuing)4.59M5.38M14.52M13.65M10.69M11.38M7.79M8.07M7.14M5.92M4.52M4.52M4.12M4.03M3.98M3.7M3.3M2.79M1.45M1.56M2.36M2.06M3.58M256K353K1.76M-6.63M513.14K-2.49M1M1M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)0.480.571.571.631.401.501.031.080.950.810.640.640.580.570.540.490.430.370.190.210.320.280.500.040.05-0.77-1.090.09-0.410.160.16
EPS Growth %-66.9%-63.69%-3.68%16.43%-6.67%45.63%-4.63%13.68%17.28%26.56%10.34%10.34%1.75%5.56%10.2%13.95%16.22%94.74%-9.52%-34.38%14.29%-44%1262.4%-29.29%106.74%29.36%-1311.11%121.95%-356.25%0%-51.52%
EPS (Basic)-0.581.581.661.421.521.051.100.990.830.650.650.600.590.560.500.450.380.200.210.330.300.540.040.06-0.77-1.090.09-0.420.170.17
Diluted Shares Outstanding9.55M9.33M9.25M8.35M7.64M7.59M7.55M7.49M7.51M7.3M7.11M7.11M7.12M7.06M7.36M7.59M7.65M7.52M7.55M7.47M7.27M7.33M7.18M6.97M6.81M6.15M6.1M5.7M6.02M6.25M6.25M
Basic Shares Outstanding9.39M9.33M9.19M8.24M7.55M7.5M7.42M7.33M7.2M7.12M6.99M6.99M6.89M6.8M7.08M7.4M7.31M7.29M7.35M7.3M7.13M6.91M6.65M6.4M5.88M6.15M6.1M5.7M5.88M5.85M5.88M
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Margin erosion from rising costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Top-Line Growth Accelerates Amid Inflation

Transcat's revenue has consistently grown, reaching $92.9M in 2027Q1, a 20.5% year-over-year increase, as reported in the latest quarterly filings, suggesting strong demand for its industrial services and distribution.

The growth trend appears durable, with revenue expanding sequentially from $82.3M in 2026Q2 to the current quarter. This consistent upward trajectory, driven by both volume and likely pricing adjustments to offset inflation, indicates the company is successfully capturing market share in a resilient industrial end-market.

Gross Margin Compression Pressures Profitability

Gross margins have declined to 33.1% in 2027Q1 from a peak of 34.0% in early 2025, based on the provided income statement data, indicating potential pressure from input costs or a less favorable product mix.

Despite revenue growth, gross margin has trended downward from its high, now sitting below the peer average of 36.7% for SPX Technologies. This structural compression suggests limited pricing power to fully pass on cost increases, which may signal a more competitive environment or rising supplier costs that are eroding the company's core profitability.

SG&A Discipline Fails to Offset Margin Pressure

Selling, General & Administrative expenses have risen significantly to $27.0M in 2027Q1 from $14.8M in 2024Q4, as shown in the quarterly data, appearing to outpace revenue growth and limiting operating leverage.

The substantial increase in SG&A, representing a nearly 82% jump over the period, suggests the company is investing in its commercial infrastructure or facing higher overhead costs. However, this expense growth has outstripped the improvement in gross profit, leading to operating margins that are now well below historical levels, which warrants investigation into the efficiency of these spending increases.

2025: Operational Profile Shifts from Leverage to Dilution

The period from 2024Q4 to 2025Q4 marks a clear inflection, where operating income fell from $9.2M to $6.9M on higher revenue, a trend that has persisted into subsequent quarters.

This inflection point appears driven by the simultaneous acceleration of SG&A growth and the onset of gross margin pressure, fundamentally altering the company's operating leverage profile. The lasting impact is a business that is growing its top line but struggling to translate that growth into bottom-line profitability, as evidenced by the sharply negative EPS growth rates reported in recent periods.

Sustainability of Growth vs. Margin Trajectory

The strongest challenge to the narrative is the consistent deterioration in operating margin, which has fallen from 13.0% in 2024Q4 to just 4.0% in 2027Q1, raising questions about the quality of the revenue growth.

While top-line expansion is positive, the margin compression implies that the growth may be coming from lower-value sales or in an environment where cost control is failing. This pattern is unsustainable long-term, as it risks the company growing into a lower-profitability entity. Investors should monitor if management can re-establish pricing power or if the current SG&A surge will eventually yield efficiency gains, otherwise, the path to recovering prior profitability levels appears challenging.

TRNS — Frequently Asked Questions

Quick answers to the most common questions about buying TRNS stock.

What was Transcat, Inc.'s (TRNS) revenue in 2026?

For fiscal year 2026, Transcat, Inc. (TRNS) reported total revenue of $331.9M. This represents a 322.8% increase compared to $78.5M in 1997.

Is Transcat, Inc. (TRNS) profitable?

Transcat, Inc. (TRNS) is profitable, generating $5.4M in net income for the fiscal year ending 2026 with a net profit margin of 1.6%.

What is Transcat, Inc.'s operating profit margin?

Transcat, Inc. (TRNS) reported an operating income of $13.3M, resulting in an operating profit margin of 4.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Transcat, Inc.'s gross profit and gross margin?

Transcat, Inc. (TRNS) generated $108.3M in gross profit for the year, representing a gross profit margin of 32.6%. This demonstrates the company's core pricing power and production efficiency.